News | BehindEveryStock

Date

1
MRVL

Marvell (MRVL) Stock Ahead of Q2 Results: What Investors Need to Know
- 📈 MRVL shares up 161% YTD, trading at $222.02.
- 💰 Analysts forecast $0.93 EPS and $2.71B revenue growth.
- 📊 Stock trades at 54.85x forward P/E vs 24.37x sector.
- 🤝 Nvidia commits $2B to Marvell's AI semiconductor pipeline.
13h ago Read article →
2
ON

The Numbers Behind ON Semiconductor’s (ON) Higher Target and Unchanged Hold Rating
- 📈 ON Semiconductor beat Q2 earnings and raised Q3 guidance above Wall Street expectations.
- 💰 Non-GAAP gross margins projected to reach 40%-42% in the third quarter.
- 🚀 AI data center revenue expected to more than double by 2026.
- ⚠️ Competitors grew revenue significantly faster than ON Semiconductor's 9%.
13h ago Read article →
3
IONQ

IonQ (IONQ) Just Posted Record Results, So Why Is The Stock Still Down ...
- 📈 Revenue surged 300% to £25.5 million this quarter.
- 💰 Net loss narrowed to £12.1 million from £20.3 million.
- 📉 Stock slipped 5% despite record financial performance.
- 💸 Company holds £150 million cash for next 12 months.
13h ago Read article →
4
ABBV

AbbVie or Bristol-Myers Squibb: Better Healthcare Stock for 2026?
- 📊 Abbvie FY2025 revenue rose 8.6% to $61.2 billion.
- 💰 Bristol-Myers Squibb revenue dipped slightly but net income recovered.
- 🧬 Abbvie reduces Humira reliance while neuroscience portfolio accelerates.
- ⚠️ Bristol-Myers Squibb risks revenue decline from Eliquis and Opdivo exclusivity losses.
13h ago Read article →
5
SYK

Stryker’s (SYK) Comeback Quarter Looks Great, But At What Cost?
- 📈 Q2 sales hit $6.6B with 9.4% volume-driven growth.
- 🔍 MedSurg and Neuro segments grew organically ~9.2%.
- 💰 Adjusted operating margin expanded to 27.4%.
- 📉 Reported EPS surged 44.1% to $3.30.
13h ago Read article →
6
BIIB

Biogen Completes Acquisition of RayThera Inc.
- 🏛️ Biogen completes acquisition of private biotech RayThera Inc.
- 💊 Deal adds small-molecule assets targeting immune-mediated conditions.
- 📅 Lead program entered Phase 1 clinical development in July 2026.
- 🚀 Acquisition drives long-term growth and pipeline diversification.
13h ago Read article →
7
ALL

Allstate Trades Above 50-Day SMA: How to Play the Stock Now?
- 📈 Shares up 8.1% YTD, trading above 50-day SMA.
- 💰 Market cap $54.9B with 1.6M avg monthly volume.
- 📊 Analysts project 2025 EPS of $21.19 and 13.7% upside.
- ⚠️ Debt-to-capital ratio is 25.2%, exceeding industry average.
13h ago Read article →
8
MCD

McDonald (MCD): A Consistent Dividend Payer Since 1976
- 📈 Matrix bought McDonald's shares at $276.26 with a 2.8% yield.
- 📉 Stock dropped 9.56% in 52 weeks but offers 2.69% dividend.
- ⚠️ Management faces headwinds from traffic drops, inflation, and price wars.
- 🤖 Firm prefers AI stocks for higher short-term returns over MCD.
13h ago Read article →
9
AMCR

Amcor plc (AMCR) Falls to Its 52-Week Low at $8.15 per share; RBC Capital Initiates Coverage with Sector Perform Rating and $9.00 PT
- 📉 Shares hit 52-week low of $8.15 on Sept 23, 2025.
- 📊 Stock declined 29% over the past year.
- 💰 RBC set $9.00 price target with Sector Perform rating.
- 🏭 Generates revenue via flexible and rigid packaging solutions.
13h ago Read article →

Cookie	Purpose	Duration
`PHPSESSID`	Session identifier for login, security tokens, and site functionality	Session
`cookie_consent`	Stores your cookie preferences	1 year

Cookie	Purpose	Duration
`_ga`	Distinguishes unique visitors (Google Analytics)	2 years
`_ga_*`	Maintains session state (Google Analytics)	2 years